Company Overview:
Salix Pharmaceuticals, Inc. follows a competitive strategy of in-licensing late-stage pharmaceutical products to treat GI diseases. The Salix portfolio includes APRISO™, COLAZAL®, XIFAXAN®, OsmoPrep®, MOVIPREP®, AZASAN®, ANUSOL-HC®, PROCTOCORT®, PEPCID® Oral Suspension, and DIURIL® Oral Suspension. Exceptional customer service, a dedicated specialty sales force, and quality products underscore Salix’s commitment to the gastroenterology community.
This Exhibitor offers products & services in the following categories: